Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Since 1994, the combination of mefloquine and artesunate is the standard treatment for uncomplicated Plasmodium falciparum malaria in the population of displaced persons on the Western border of Thailand. As a result, the fall of mefloquine efficacy was stopped and the incidence of falciparum malaria reduced. This is attributed to the effects of the artemisinin derivatives on transmissibility. Similar trends were observed in Vietnam where artemisinin is widely used. Combination therapies that include an artemisinin derivative could have a major role in the control of malaria and the spread of drug resistance.


Journal article


Med Trop (Mars)

Publication Date





45 - 49


Antimalarials, Artemisinins, Drug Resistance, Drug Therapy, Combination, Humans, Incidence, Malaria, Falciparum, Malaria, Vivax, Mefloquine, Prospective Studies, Refugees, Risk Factors, Seasons, Sesquiterpenes, Thailand, Treatment Outcome, Vietnam